Shock waves could soften hand contractures without surgery

NCT ID NCT06248866

Completed Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether extracorporeal shock wave therapy can reduce the thickness of fibrous tissue in the hand caused by palmar fibromatosis (Dupuytren's contracture). Adults aged 18 to 70 with nodules, cords, or contractures will receive either shock wave therapy plus standard care or standard care alone. Researchers will measure changes in lesion thickness using ultrasound and assess hand function with a questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: extracorporeal shock wave therapy
What this could lead to: If it works, this could offer a non-surgical option to reduce nodules and cords in the hand and improve daily function.
What could go wrong: This is a small, early-stage trial with 60 participants, so results may not apply broadly. The therapy may not shrink lesions or improve symptoms significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates